As a cardiologist, Topol has always championed aerobic exercise to reduce the risk of heart disease. Since studying the ...

The FDA cleared marketing for the first in vitro diagnostic device that tests blood to aid in diagnosing Alzheimer disease.

Highlights: Artificial intelligence identifies hidden heart disease risk in routine bone scans Abdominal aortic calcification is a stronger fracture predictor than bone density Vascular health ...

A bone density scan can detect thinning bones at an early stage. If you already have osteoporosis, bone scans can also tell you how fast the disease is progressing. But an abnormal bone scan can ...

The Lumipulse blood test identifies the presence of amyloid plaques, a hallmark of Alzheimer’s disease that impairs normal brain function.

A new study presented at COMy 2025 reveals that patients with amyloid light-chain amyloidosis still face significant delays ...

About 58 per cent of older women undergoing routine bone scans showed moderate to high levels of AAC, many of them unaware of the elevated cardiovascular risk, ECU research fellow Cassandra Smith ...

using standard bone density scans, according to a statement Tuesday by Australia’s Edith Cowan University (ECU). Created in partnership with the University of Manitoba, the automated system ...

Amyloid-positive (left) and amyloid-negative (right) PET scans can respectively be used to diagnose or rule out Alzheimer's disease in individuals with memory loss or cognitive decline. Disclaimer ...

The CHMP also adopted a positive opinion for Attrogy (diflunisal) for the treatment of hereditary TTR–mediated amyloidosis in adult patients with stage I or stage II polyneuropathy. The ...